SUPN
Supernus Pharmaceuticals, Inc.Healthcare$50.48
▼ Bearish
Mkt Cap: $2.91B|Float: 51.8M|SI: 8.1%|DTC: 4.8
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
34.3%
52W Range
$29-$60
ATR(14)
$1.89
Exp. Move
±16.8%
P/C Ratio
3.42
Earnings
May 5
GEX Negative
DEX Long
Net Put Premium
IV High
Max Pain Below
Exp. Move Wide
High Put/Call
SUPN Key Options Data
- IV Rank
- 100%
- Total GEX
- $-0.00B
- Total DEX
- $0.1M
- Max Pain
- $45.00
- Expected Move
- ±16.8%
- Put/Call OI
- 3.42
- Net Premium
- $-0.0M
- Spot Price
- $50.48
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-06-18 | 77 | ±$8.50 | ±16.8% | $41.98 | $58.98 |
| 2026-09-18 | 169 | ±$6.25 | ±12.4% | $44.23 | $56.73 |
| 2026-12-18 | 260 | ±$7.25 | ±14.4% | $43.23 | $57.73 |
| 2027-01-15 | 288 | ±$17.50 | ±34.7% | $32.98 | $67.98 |
Explore SUPN options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.